Accelera Innovations Inc (ACNV) financial statements (2020 and earlier)

Company profile

Business Address 20511 ABBEY DR.
FRANKFORT, IL 60423
State of Incorp.
Fiscal Year End December 31
SIC 80 - Health Services (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2017
TTM
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments  000 
Cash and cash equivalents  000 
Receivables 0 1  
Prepaid expense   0 
Other undisclosed current assets  0 1 
Total current assets: 0111 
Noncurrent Assets
Property, plant and equipment 000  
Intangible assets, net (including goodwill)    5
Goodwill    5 
Other undisclosed noncurrent assets  00  
Total noncurrent assets: 0005 
TOTAL ASSETS: 0116 
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 1100 
Accounts payable 0000 
Accrued liabilities 000  
Debt 1510 
Derivative instruments and hedges, liabilities 00   
Due to related parties 000  
Deferred revenue and credits   0  
Other undisclosed current liabilities 0 10 
Total current liabilities: 2720 
Noncurrent Liabilities
Long-term debt and lease obligation  0   
Long-term debt, excluding current maturities  0   
Other undisclosed noncurrent liabilities   56 
Total noncurrent liabilities:  056 
Total liabilities: 2766 
Stockholders' equity
Stockholders' equity attributable to parent, including: (2)(6)(6)(0)5
Common stock 00000
Additional paid in capital 595643125
Accumulated deficit (62)(64)(49)  
Other undisclosed stockholders' equity attributable to parent 02 (13) 
Total stockholders' equity: (2)(6)(6)(0)5
TOTAL LIABILITIES AND EQUITY: 01165

Income statement (P&L) ($ in millions)

9/30/2017
TTM
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues 0430 
Cost of revenue (0)(2)(2)  
Financial services costs (0)(2)   
Other undisclosed gross profit 0    
Gross profit: 0210 
Operating expenses (2)(15)(33)(8)(5)
Operating loss: (2)(13)(32)(7)(5)
Nonoperating expense (0)(2)(0)  
Investment income, nonoperating   (0)  
Interest and debt expense (0)    
Loss from continuing operations before equity method investments, income taxes: (2)(15)(32)(7)(5)
Other undisclosed income from continuing operations before income taxes 0    
Loss from continuing operations before income taxes: (2)(15)(32)(7)(5)
Income tax benefit   28  
Loss from continuing operations: (2)(15)(4)(7)(5)
Income (loss) from discontinued operations 2 (0)  
Net loss: (0)(15)(4)(7)(5)
Other undisclosed net loss attributable to parent (2) (32)  
Net loss attributable to parent: (2)(15)(36)(7)(5)
Other undisclosed net loss available to common stockholders, basic (0)(0)   
Net loss available to common stockholders, diluted: (2)(15)(36)(7)(5)

Comprehensive Income ($ in millions)

9/30/2017
TTM
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net loss: (0)(15)(4)(7)(5)
Comprehensive loss, net of tax, attributable to parent: (0)(15)(4)(7)(5)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: